awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26749278-26378CA2-1D26-48D0-8A38-C194D402E432
Q26749278-26378CA2-1D26-48D0-8A38-C194D402E432
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26749278-26378CA2-1D26-48D0-8A38-C194D402E432
New and emerging targeted therapies for cystic fibrosis
P2860
Q26749278-26378CA2-1D26-48D0-8A38-C194D402E432
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26749278-26378CA2-1D26-48D0-8A38-C194D402E432
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4f1b0d4fed16ba87639d21797182a00ac23df8fc
P2860
A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial.